Inari Medical Inc. (NARI): Price and Financial Metrics

Inari Medical Inc. (NARI): $43.08

2.22 (-4.90%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

B

NARI Price/Volume Stats

Current price $43.08 52-week high $71.85
Prev. close $45.30 52-week low $36.73
Day low $42.81 Volume 583,138
Day high $45.95 Avg. volume 1,090,733
50-day MA $44.00 Dividend yield N/A
200-day MA $54.29 Market Cap 2.50B

NARI Stock Price Chart Interactive Chart >


Inari Medical Inc. (NARI) Company Bio


Inari Medical, Inc. operates as a medical device company. It develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.


NARI Latest News Stream


Event/Time News Detail
Loading, please wait...

NARI Latest Social Stream


Loading social stream, please wait...

View Full NARI Social Stream

Latest NARI News From Around the Web

Below are the latest news stories about INARI MEDICAL INC that investors may wish to consider to help them evaluate NARI as an investment opportunity.

Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 9:45AM Pacific Time. A live audio webcast and replay of the presentation may be accessed for 30 days on the “Investor Relatio

Yahoo | December 20, 2023

Reasons to Retain Inari Medical (NARI) in Your Portfolio Now

Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on the adoption of products is a concern.

Yahoo | December 15, 2023

Why Is Steris (STE) Down 3.4% Since Last Earnings Report?

Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2023

Inari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue?

Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 1, 2023

Inari Medical's (NARI) PEERLESS II RCT to Boost Patient Outcome

Inari Medical's (NARI) latest announcement of first patient enrollment in PEERLESS II RCT is likely to aid in changing guidelines in treating intermediate-risk PE patients globally.

Yahoo | November 30, 2023

Read More 'NARI' Stories Here

NARI Price Returns

1-mo -5.84%
3-mo -4.80%
6-mo -31.53%
1-year -26.16%
3-year -53.52%
5-year N/A
YTD -33.64%
2023 2.14%
2022 -30.36%
2021 4.56%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!